Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
女性癌症的长期多学科研究:护士健康研究
基本信息
- 批准号:8699413
- 负责人:
- 金额:$ 297.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-22 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAgingArchivesBehaviorBehavioralBehavioral GeneticsBig DataBiological MarkersBloodBlood specimenBody mass indexBreastCancer EtiologyCancer PatientCancer SurvivorCellsCollectionColorectalColorectal CancerComplementComplexComputer softwareDNADataData AnalysesData SourcesDevelopmentDiagnosisDiagnosticEnvironmentEtiologyFilmFutureGenomicsGoalsHealthHealth PolicyHeterogeneityIncidenceInstitute of Medicine (U.S.)InvestmentsLeadershipLife StyleMailsMalignant NeoplasmsMammographyMeasurementMeasuresMedicareMedicare claimMental HealthMethodsMorbidity - disease rateNurses&apos Health StudyOvarianParticipantPathway interactionsPhysical FunctionPhysical activityPilot ProjectsPlasmaPositioning AttributePreventionPreventiveProceduresQuality of lifeQuestionnairesRecurrenceResearchResearch InfrastructureResearch PersonnelResearch SupportResource SharingResourcesRisk FactorsSamplingSeminalSpecimenStatistical ModelsStructureStructure of nail of toeSystemSystems BiologyTimeTime StudyTissue BanksTissuesTumor TissueUnited States National Institutes of HealthUpdateUrineWomanWorkagedbasebehavior measurementbiobankbreast densitycancer diagnosiscancer preventioncancer sitecancer therapycohortcostdata managementdata sharingdigitalexperiencefollow-upgenome wide association studyhealth care service utilizationhealth economicsimprovedinnovationmalignant breast neoplasmmetabolomicsmiddle agemortalitymultidisciplinarynovelrepositorysample collectionscreeningtranscriptomicstumor
项目摘要
DESCRIPTION (provided by applicant): This is a UIVII application to support the infrastructure of the original Nurses' Health Study (NHS). The NHS began in 1976 with 121,700 women, and has accumulated data from 19 questionnaires over 37 years; follow-up remains about 90 percent. The wealth of behavioral data combined with multiple bio-specimen collections, including blood, toenails, urine, buccal cells and tumor tissues beginning in 1.983 from a substantial proportion of women, provide an unparalleled resource in studying cancer prevention, etiology, and survival. Sustained follow-up of the NHS through repeated questionnaire mailings and continued identification of cancer incidence and mortality will permit critical new research. With the cohort's maturation (women are now 66+ years, at peak ages for cancer incidence), we propose to add emphasis to two overarching themes. First, we propose to expand the infrastructure for cancer survival research, including both the duration and quality of life in cancer patients. The many years of characterization of cancer patients before and after diagnosis, will allow us to distinguish between causes and consequences of cancer and its treatment. Second, we propose to improve our infrastructure to support a systems biology approach to our research, integrating questionnaire data with biomarkers in DNA, blood, tumor tissue, and other bio specimens; such research simultaneously integrating multiple "systems", including behavior, genomics, transcriptomics, metabolomics, etc., may illuminate new mechanisms underlying cancer. Our large and growing number of incident cancer cases, and the unique combination of questionnaires and bio specimens, are a necessity for such integrative research. Specifically, our Aims include new collection of quality of life data, new (collection of tumor tissue (resulting in tissue collections, across 17 cancer sites), improved dat management/statistical support for "big data" analyses, and enhanced infrastructure for data sharing (the NHS resource is already extensively utilized - we have provided access to >75 external investigators in the past 5-6 years and 27 NCI cancer consortia). The NHS structure combines the long experience of senior leaders with support of several developing leaders; this combination is purposeful, to maintain leadership to sustain the cohort's future. In conclusion, NHS is well-positioned to continue cutting-edge research to reduce cancer morbidity and mortality. With the previous investment from NIH and investigators, the incremental costs of continuing this cohort are modest in relation to the uniquely valuable findings that will emerge in
the coming 5 years.
描述(由申请人提供):这是一份UIVII申请,用于支持原始护士健康研究(NHS)的基础设施。国民保健制度始于1976年,有121700名妇女参与,并在37年的时间里从19份问卷中积累了数据;随访率约为90%。丰富的行为数据与多种生物标本收集相结合,包括血液、脚趾甲、尿液、颊细胞和肿瘤组织,从1983年开始,来自相当大比例的女性,为研究癌症预防、病因和生存提供了无与伦比的资源。通过重复的问卷邮寄和继续确定癌症发病率和死亡率,NHS的持续随访将允许进行重要的新研究。随着队列的成熟(女性现在66岁以上,是癌症发病率的高峰年龄),我们建议强调两个首要主题。首先,我们建议扩大癌症生存研究的基础设施,包括癌症患者的生存时间和生活质量。多年来对癌症患者诊断前后的特征描述,将使我们能够区分癌症及其治疗的原因和后果。其次,我们建议改善我们的基础设施,以支持系统生物学方法来进行我们的研究,将问卷数据与DNA、血液、肿瘤组织和其他生物标本中的生物标志物相结合;这种研究同时整合了多个“系统”,包括行为、基因组学、转录组学、代谢组学等,可能会揭示癌症的新机制。我们大量且不断增长的癌症病例,以及问卷调查和生物标本的独特结合,是这种综合研究的必要条件。具体来说,我们的目标包括新的生活质量数据收集,新的肿瘤组织收集(导致组织收集,跨越17个癌症站点),改进的数据管理/“大数据”分析的统计支持,以及增强的数据共享基础设施(NHS资源已经被广泛利用-我们在过去的5-6年中已经提供了bb1075外部调查人员和27 NCI癌症联盟)。NHS结构结合了高级领导人的长期经验和几个发展中领导人的支持;这种组合是有目的的,以保持领导地位,以维持队列的未来。总之,NHS有能力继续进行尖端研究,以降低癌症发病率和死亡率。有了先前NIH和研究人员的投资,继续这个队列的增量成本相对于将出现的独特的有价值的发现来说是适度的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Meir Stampfer其他文献
Meir Stampfer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Meir Stampfer', 18)}}的其他基金
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
女性癌症的长期多学科研究:护士健康研究
- 批准号:
9099795 - 财政年份:2014
- 资助金额:
$ 297.21万 - 项目类别:
Growth Factors and Lethal Prostate Cancer Signature
生长因子和致命的前列腺癌特征
- 批准号:
8264785 - 财政年份:2010
- 资助金额:
$ 297.21万 - 项目类别:
Growth Factors and Lethal Prostate Cancer Signature
生长因子和致命的前列腺癌特征
- 批准号:
7898033 - 财政年份:2010
- 资助金额:
$ 297.21万 - 项目类别:
Growth Factors and Lethal Prostate Cancer Signature
生长因子和致命的前列腺癌特征
- 批准号:
8063879 - 财政年份:2010
- 资助金额:
$ 297.21万 - 项目类别:
Growth Factors and Lethal Prostate Cancer Signature
生长因子和致命的前列腺癌特征
- 批准号:
8444277 - 财政年份:2010
- 资助金额:
$ 297.21万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Operating Grants
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 297.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)